OIMU
RPRX icon

Osmosis Investment Management UK’s Royalty Pharma RPRX Stock Holding History

Osmosis Investment Management UK’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$497K Sell
8,862
-6,404
-42% -$333K 0.02% 356
2026
Q1 		$732K Sell
15,266
-7,553
-33% -$331K 0.02% 357
2025
Q4 		$882K Buy
+22,819
New +$870K 0.02% 300

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osmosis Investment Management UK's RPRX Position: Q2 2026 in Review

Osmosis Investment Management UK reduced its Royalty Pharma (RPRX) stake by 42% in Q2 2026, selling an estimated $333K and leaving 8,862 shares worth $497K. The position accounts for 0.02% of the portfolio, ranked #356.

Osmosis Investment Management UK first reported a position in RPRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $882K in Q4 2025. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Osmosis Investment Management UK held 8,862 shares of Royalty Pharma worth $497K as of Q2 2026.
  • Osmosis Investment Management UK sold 6,404 Royalty Pharma shares in Q2 2026, an estimated $333K.
  • Royalty Pharma made up 0.02% of Osmosis Investment Management UK's portfolio in Q2 2026, its #356 holding.
  • Osmosis Investment Management UK first reported a position in Royalty Pharma in Q4 2025 and has held it in 3 quarters since.
  • Osmosis Investment Management UK's Royalty Pharma position peaked at $882K in Q4 2025.
  • 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Osmosis Investment Management UK's 13F filing for Q2 2026, filed 13 Aug 2026.